Search

Adam Darkins

Dr Adam Darkins has unique experience in taking national and trans-national virtual care delivery systems to scale. Dr Darkins developed an extensive understanding of patient care, clinical processes, and outcomes measurement from his physician training at Manchester University Medical School, UK, and further training/accreditation as a neurosurgeon and researcher at UCLA. Studying public health medicine at the London School of Hygiene and Tropical Medicine, and pioneering shared patient decision-making programs at the King’s Fund, London, grounded him in leading transformative change with a particular talent for safely and effectively taking long-established hospital-based practice into primary care, community care and non-traditional settings. Dr Darkins gained widespread US and international recognition for his leadership of telehealth programs at the US Department of Veterans Affairs (VA) where he developed health informatics, telehealth and disease management technologies to enhance and extend care and case management. Together with his team, Dr Darkins created a capacity that delivered virtual services to more than 480,000 Veteran patients each year via 1.4 million episodes of care. Dr Darkins is vice president for innovation and strategic partnerships for the Americas Region at Medtronic and has been permanently based in the USA since 1997. Dr Darkins serves on the editorial board of Telehealth and e-Health Journal; is a former Medical Director in London; co-founded a start-up telehealth company; and has both written, and spoken widely on how to address the challenges and find solutions in establishing large virtual health care networks that meet major health care priorities and deliver high volumes of patient consultation/care as their return on investment.
Bio last updated 15 Dec 2018

Article Timeline

Positions - Previous

PositionCompanyYearCompany's current rankWA staff
Non-Executive Deputy Chairman
Medibio
Medibio
2017 - 2018126

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
24thProteomics International Laboratories167%
248thMejority Capital5%-8%
446thTransaction Solutions International-22%-0%
723rdMyFiziq-61%
838thMedibio-88%-33%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Revenue

126th↓Medibio$2.5m
128th↑Transaction Solutions International$2.3m
129th↓Proteomics International Laboratories$2.1m
131st↑MyFiziq$2.1m
132nd↓Mejority Capital$2.1m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer